jili golden empire
A man charged with attempted murder has had his bid for bail rejected when the grandmother he claimed caring for said she hadn't seen him for months. Black Friday Sale Subscribe Now! Login or signup to continue reading All articles from our website & app The digital version of Today's Paper Breaking news alerts direct to your inbox Interactive Crosswords, Sudoku and Trivia All articles from the other regional websites in your area Continue The gruesome machete attack he is accused of carrying out left his alleged victim requiring 14 hours of lifesaving surgery. Zachery Norton faced the ACT Magistrates Court on Friday, more than two months after police claim he fled the bloody scene and his friend. The 30-year-old alleged attacker denied a single charge of attempted murder. "Not guilty, your honour," the Garran man said, before sweating profusely throughout his bail proceedings. Norton patted his forehead with tissues, cried and frequently turned in his chair to look around at the court public gallery. But the man could not show special or exceptional circumstances warranted the court hearing his bid for conditional freedom. The more difficult legal threshold was set due to the seriousness of his crime and, as a result, he was denied bail. Norton appeared more agitated in his seat as it became clear he would be staying in custody rather than walking out through the court building's front doors. The weapon police believe was used in the September attack. Picture by ACT Policing The alleged attack Police and emergency services attended a home in Wanniassa on September 4, when they found the alleged victim "slumped in the entry of the unit" and suffering from life-threatening injuries. That man was treated for multiple deep incisions and fractures before being taken to hospital, where he was placed in an induced coma for four days. Police documents tendered in court allege the weapon used in the attack was a 25-inch Gerber Gator-branded machete. Norton is accused of using the weapon to sever three of the alleged victim's fingers and cause numerous other grisly injuries. Police stopped the alleged attacker on Thursday as he tried to get on a bus travelling to Yass. Grandmother claim falls through Norton's Friday bail application revolved around a number of factors, headlined by the claim he was a "carer for his elderly grandmother". But when the court reconvened after a lunch break, prosecutor David Swan relayed information from the case's police informant. The grandmother in question had just told that officer she "has not seen [Norton] for at least three months". MORE COURT AND CRIME NEWS : 'Screaming but no one could hear,' victim says 45 years after sexual abuse Allegedly negligent truck driver charged over death of motorcyclist Man accused of cultivating 164 cannabis plants in 'sophisticated' grow house "Obviously in those circumstances, given that the defendant hasn't sought to challenge that conclusion, that first plank of the application falls away," Special Magistrate Marcus Hassall said. Mr Hassall found other factors were not special or exceptional, including an upcoming "foot specialist appointment" which had reportedly taken nine months to book. At the time of the alleged attack, Norton was on bail for several other charges including robbery, dangerous driving and attempt to escape custody or arrest. He is set to return to court next year. Witnesses sought ACT Policing has urged any witnesses to the September incident to come forward. "Investigators are confident that there are further witnesses who can provide important information about the attack and the movements of the alleged offender afterwards," a spokesperson said. "Police are also seeking information about the weapon believed to have been used during the assault. Anyone who has seen it, or knows its location, is urged to come forward." Anyone with information that can assist police or who may have witnessed the incident is urged to contact Crime Stoppers on 1800 333 000 or via the Crime Stoppers ACT website . Please quote reference number 7842338. Information can be provided anonymously. Support is available for those who may be distressed. Phone Lifeline 13 11 14; beyondblue 1300 224 636. Share Facebook Twitter Whatsapp Email Copy Tim Piccione Court reporter Tim is a journalist with the Canberra Times covering the ACT courts. He came to the nation's capital via the Daily Advertiser in Wagga. Contact: tim.piccione@canberratimes.com.au. Tim is a journalist with the Canberra Times covering the ACT courts. He came to the nation's capital via the Daily Advertiser in Wagga. Contact: tim.piccione@canberratimes.com.au. More from Canberra Raiders' travel requests revealed in wake of horror 2025 NRL draw 27m ago No comment s Oh my stars! Snake tries to break into the Mount Stromlo Observatory 1hr ago No comment s 'Troubling': Audit finds transparency problems with how levy is spent 2hrs ago No comment s We can't trust bipartisan hands in our pockets No comment s It's almost time! Nagi Maehashi (and Dozer) from RecipeTin Eats are in town Discover the abandoned lookouts of Mt Ainslie - check out those views! No comment s Newsletters & Alerts View all DAILY Your morning news Today's top stories curated by our news team. Also includes evening update. Loading... WEEKDAYS The lunch break Grab a quick bite of today's latest news from around the region and the nation. Loading... DAILY Sport The latest news, results & expert analysis. Loading... WEEKDAYS The evening wrap Catch up on the news of the day and unwind with great reading for your evening. Loading... WEEKLY Note from the Editor Get the editor's insights: what's happening & why it matters. Loading... WEEKLY FootyHQ Love footy? We've got all the action covered. Loading... DAILY Early Look At David Pope Your exclusive preview of David Pope's latest cartoon. Loading... AS IT HAPPENS Public Service News Don't miss updates on news about the Public Service. Loading... WEEKLY Explore Travel Every Saturday and Tuesday, explore destinations deals, tips & travel writing to transport you around the globe. Loading... WEEKLY Property Get the latest property and development news here. Loading... WEEKLY What's On Going out or staying in? Find out what's on. Loading... WEEKLY Weekend Reads We've selected the best reading for your weekend. Loading... WEEKLY Times Reader's Panel Join our weekly poll for Canberra Times readers. Loading... WEEKDAYS The Echidna Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more. Loading... TWICE WEEKLY The Informer Your essential national news digest: all the big issues on Wednesday and great reading every Saturday. Loading... WEEKLY Motoring Get news, reviews and expert insights every Thursday from CarExpert, ACM's exclusive motoring partner. Loading... TWICE WEEKLY Voice of Real Australia Get real, Australia! Let the ACM network's editors and journalists bring you news and views from all over. Loading... AS IT HAPPENS Breaking news alert Be the first to know when news breaks. Loading... DAILY Today's Paper Alert Your digital replica of Today's Paper. Ready to read from 5am! Loading... DAILY Your favourite puzzles Test your skills with interactive crosswords, sudoku & trivia. Fresh daily! Loading...The J. M. Smucker Company Announces Pricing for Cash Tender Offers
Highlights from Trump's interview with Time magazineJustin Trudeau taking the time to reflect after Chrystia Freeland's departure
I was born and raised in Philadelphia and loved it. But when it came time for college, I was accepted into Stanford. I've always been really interested in green technology, renewable energy, and solar stuff. I studied material science engineering as an undergrad, and then I stayed for a fifth year and got my master's degree in electrical engineering. After graduating, I spent almost three years living in the Bay Area, working at Applied Materials, a semiconductor company. I lived in San Francisco, right on the edge of Mission and Portero Hill, and commuted to work in Santa Clara. In the 2010s and early 2020s, California was the place to be if you wanted to do tech, engineering, or renewable energy. At Applied Materials, I was learning how to be an engineer in the real world. But I wasn't working on energy efficiency or renewable energy, which was my dream. I found that I was clashing with the culture of Silicon Valley. There are a ton of amazing people there, but generally speaking, I felt like people could be "fake nice." I attributed that attitude to the Silicon Valley atmosphere. I don't want to call it cutthroat, but it was tough at times to join a community of really driven people who would sometimes drive themselves over the edge. I'm more of a "go-at-your-own-pace" kind of person. I don't think 16-hour days are a path to success. In Silicon Valley, you have a lot of Google people, a lot of Meta people, and, at the time I was there, a lot of Tesla people. And that's the core of who they are. I grew tired of the way people would define themselves by their jobs rather than who they are as a person. After graduating, I was worried I would have to choose between staying in California and having a career I liked or leaving California and having a career I didn't like. The career opportunities in Silicon Valley seemed more abundant. But ending up with a career that wasn't what I wanted while I was in California helped push me to take the next step. In 2022, I started applying to East Coast jobs, specifically looking for roles in renewable energy. I got an offer from my current workplace, Carbon Reform, in September 2022. They're a Philadelphia-based startup working on sustainability. It was right up my alley. I moved back and started at the end of November 2022. I definitely had some nerves before moving. I was questioning whether this was right for my career. The sustainability hub is in Silicon Valley, and moving to the other side of the country felt like I was separating myself from that. But I was also so excited. It felt surreal that I had found something I wanted to do, and I got the bonus of being on the East Coast. At Carbon Reform, we're working on devices that connect to HVAC systems in existing office buildings. They remove the carbon dioxide from the workspace air and allow you to recycle the air without having to bring in new air from outside. I love my work now. I'm feeling a lot more fulfilled. It was so expensive to live in California. I had to live with two roommates to afford the cost of living, and that was for a spot on the edge of San Francisco. Now, I have my own space in Philly. I pay about the same as I was paying in California, where I was splitting with three people. I moved to a Philly neighborhood called Rittenhouse. It's a combination of older people and a bunch of young professionals and grad students who live there. There's always something to do around here. It's close to a huge park where they have shows and dining. It's a great way to meet new people and not break the bank. We also have an incredible sports scene here. Between the Eagles and the Phillies, sometimes Philadelphia feels like a big college town. Philly's tech and business scene is growing. We have the University of Pennsylvania and Drexel University right in the city. There are incredible students coming out of those schools. I think the city has started taking advantage of all those really intelligent people. It seems like Philadelphia is putting in the work to try to keep them. That said, Philly still seems like a little secret sometimes. I don't want to tell everybody about it because once the secret is out, people will move here, and costs will go up. It's in a really unique pocket location-wise. You have the financial capital of New York nearby and the political capital of DC close, too. You get the benefits of both without the negative effects. I miss parts of California sometimes. I miss my friends and the access to incredible types of food. But my hope is to stay in Philly for the long term. As long as I have a job and am getting paid what I think I should be making, my goal is to be here. Read the original article onWere you a better-than-average golfer in 2024? This new data will tell you
Even with access to blockbuster obesity drugs, some people don't lose weight Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Jonel Aleccia, The Associated Press Nov 23, 2024 6:10 AM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home, March 1, 2024, in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content. Jonel Aleccia, The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message More The Mix UN talks in disarray as a rough draft deal for climate cash is rejected by developing nations Nov 23, 2024 6:15 AM These Peruvian women left the Amazon, but their homeland still inspires their songs and crafts Nov 23, 2024 5:43 AM Ottawa to deliver apology, $45M in compensation for Nunavik Inuit dog slaughter Nov 23, 2024 3:00 AM Featured Flyer
- Previous:
- Next: golden empire jili
